Segall Bryant & Hamill, LLC Bristol Myers Squibb CO Transaction History

Segall Bryant & Hamill, LLC

$5.57 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $83,361 - $93,211	-1,440 Reduced 1.8%	78,544 $4.56 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $113,722 - $126,270	-1,785 Reduced 2.18%	79,984 $5.11 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $45,996 - $52,171	-700 Reduced 0.85%	81,769 $5.67 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $13,696 - $16,218	200 Added 0.24%	82,469 $5.93 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $82 - $48,639	-633 Reduced 0.76%	82,269 $5.85 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $212,413 - $233,941	2,925 Added 3.66%	82,902 $6.38 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $621,562 - $745,309	-10,110 Reduced 11.22%	79,977 $5.84 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $419,225 - $488,718	-7,817 Reduced 7.98%	90,087 $5.62 Million
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $1.1 Million - $1.29 Million	18,565 Added 23.4%	97,904 $5.79 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $74,911 - $81,578	1,210 Added 1.55%	79,339 $5.3 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $363,576 - $408,915	-6,127 Reduced 7.27%	78,129 $4.93 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $198,163 - $224,555	-3,432 Reduced 3.91%	84,256 $5.23 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $38,190 - $42,320	665 Added 0.76%	87,688 $5.29 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $747,251 - $873,610	-13,631 Reduced 13.54%	87,023 $5.12 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $218,219 - $317,123	-4,703 Reduced 4.46%	100,654 $5.61 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $516,065 - $673,160	10,487 Added 11.05%	105,357 $6.76 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $227,365 - $269,574	-5,316 Reduced 5.31%	94,870 $4.81 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $205,832 - $227,605	-4,613 Reduced 4.4%	100,186 $0
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $161,529 - $192,604	-3,580 Reduced 3.3%	104,799 $0
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $6,095 - $7,903	-125 Reduced 0.12%	108,379 $5.63 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $614,540 - $693,153	-11,135 Reduced 9.31%	108,504 $0
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $3.45 Million - $4.3 Million	68,228 Added 132.71%	119,639 $0
Q1 2018 May 16, 2018	BUY	$59.92 - $68.98 $38,288 - $44,078	639 Added 1.26%	51,411 $0
Q4 2017 Feb 15, 2018	SELL	$59.94 - $65.35 $68,211 - $74,368	-1,138 Reduced 2.19%	50,772 $0
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $2.87 Million - $3.31 Million	51,910	51,910 $0

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account